NatSynDrugs is the acronym of the European Research Centre for Drug Discovery and Development, an international multidisciplinary research network that encompasses Universities and Institutes that have a major commitment to the development of innovative drugs.
NatSynDrugs is constituted by core groups who have the knowledge and skills for each stage of drug development: from basic molecular research through proof-of-principle to pre-clinical testing. Each research group contributes complementary skills to the Centre to facilitate a complete drug development programme.
NatSynDrugs may establish a lead in a new drug development paradigm and will facilitate the transfer of knowledge and innovative technologies among Italian and European groups. The research programmes are supported by grants from the Italian Ministry of Health and the Italian Ministry for Education, from the European Community, and from Pharmaceutical Companies.